Intervention not reported
PUFA(3 RCT; 301 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
It is very uncertain whether the intervention changes PUFA(3 RCT; 301 participants) (very low certainty).
1 finding from 1 review
OR 1.31 [0.49, 4]
Studies not reported
Very low
Intervention not reported
PUFA plus vitamin E(1 trial; 70 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Phospholipids plus PUFA plus vitamin E(1 trial; 40 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
PUFA plus other supplements(1 trial; 38 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
PUFA(2 trials; 58 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
PUFA(2 trials; 95 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
PUFA(9 trials; 750 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
All allergic disease ‐ Infancy (incidence) · infants
It is very uncertain whether higher changes all allergic disease ‐ infant incidence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
All allergic disease ‐ childhood prevalence · infants
It is very uncertain whether higher changes all allergic disease ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
Asthma ‐ childhood prevalence · infants
It is very uncertain whether higher changes asthma ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
Dermatitis/eczema ‐ childhood prevalence · infants
It is very uncertain whether higher changes dermatitis/eczema ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
Allergic rhinitis ‐ childhood prevalence · infants
It is very uncertain whether higher changes allergic rhinitis ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
Food allergy ‐ childhood prevalence · infants
It is very uncertain whether higher changes food allergy ‐ childhood prevalence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
Asthma ‐ Infancy (incidence) · infants
Higher showed no clear difference in asthma ‐ infant incidence compared with lower PUFA intake (low certainty).
1 finding from 1 review
Eczema ‐ Infancy (incidence) · infants
It is very uncertain whether higher changes dermatitis/eczema ‐ infant incidence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
Allergic rhinitis ‐ infant incidence · infants
It is very uncertain whether higher changes allergic rhinitis ‐ infant incidence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
Food allergy ‐ Infancy (incidence) · infants
It is very uncertain whether higher changes food allergy ‐ infant incidence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
All allergic disease ‐ childhood (incidence) · infants
It is very uncertain whether higher changes all allergic disease ‐ childhood incidence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
Asthma ‐ childhood (incidence) · infants
It is very uncertain whether higher changes asthma ‐ childhood incidence compared with lower PUFA intake (very low certainty).
1 finding from 1 review
Eczema ‐ childhood (incidence) · infants
It is very uncertain whether higher changes dermatitis/eczema ‐ childhood incidence compared with lower PUFA intake (very low certainty).
1 finding from 1 review